Market Cap 1.48B
Revenue (ttm) 2.01B
Net Income (ttm) -99.07M
EPS (ttm) N/A
PE Ratio 9.88
Forward PE 10.00
Profit Margin -4.92%
Debt to Equity Ratio 0.73
Volume 919,600
Avg Vol 801,976
Day's Range N/A - N/A
Shares Out 87.08M
Stochastic %K 84%
Beta 1.26
Analysts Sell
Price Target $17.07

Company Profile

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-ba...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 954 384 0175
Address:
1301 Concord Terrace, Sunrise, United States
SirBensonbot
SirBensonbot Oct. 2 at 11:21 AM
$MD long
0 · Reply
highnihilism
highnihilism Oct. 1 at 11:17 AM
$UTES Virtus Reaves Utilities ETF Trades: 1 | Total $: 820 | 0.00 × 90-Day Avg $: 820 | Call $: 820 | Put $: 0 | Single-Leg: 100% | Multi-Leg: – | Contingent: – $PUK Prudential Public Limited Company Trades: 3 | Total $: 820 | 0.12 × 90-Day Avg $: 6.6 K | Call $: 820 | Put $: 0 | Single-Leg: 100% | Multi-Leg: – | Contingent: – $KCE SPDR S&P Capital Markets ETF Trades: 2 | Total $: 819 | 1.11 × 90-Day Avg $: 740 | Call $: 819 | Put $: 0 | Single-Leg: – | Multi-Leg: – | Contingent: 100% $MD Pediatric Medical Group Trades: 7 | Total $: 1.5 K | 0.51 × 90-Day Avg $: 3 K | Call $: 819 | Put $: 702 | Single-Leg: 100% | Multi-Leg: – | Contingent: –
0 · Reply
highnihilism
highnihilism Sep. 29 at 6:28 PM
S&P MidCap 400 (Health Care) → $INCY Incyte $JAZZ Jazz Pharmaceuticals $LH Laboratory Corp. of America $MD Mednax $MOH Molina Healthcare
0 · Reply
highnihilism
highnihilism Sep. 24 at 7:12 PM
Russell 2000 (Healthcare) → $JAZZ Jazz Pharmaceuticals $LH Labcorp $LMAT LeMaitre Vascular $MD Mednax $MDGL Madrigal Pharmaceuticals
0 · Reply
highnihilism
highnihilism Sep. 24 at 12:33 PM
Russell 2000 (Healthcare) → $JAZZ Jazz Pharmaceuticals $LH Labcorp $LMAT LeMaitre Vascular $MD Mednax $MDGL Madrigal Pharmaceuticals
0 · Reply
highnihilism
highnihilism Sep. 17 at 10:13 AM
IWM: Russell 2000 → $MD Pediatrix Medical Group $ARKO Arko Corp. $OSW OnespaWorld $CTLP Cantaloupe $BHR Braemar Hotels & Resorts
0 · Reply
ZacksResearch
ZacksResearch Sep. 12 at 6:28 PM
$MD up 29.6% YTD — time to take notice? 🚀 With a low forward P/E of 9.46 and a Zacks Rank #1 (Strong Buy), Pediatrix Medical is outpacing the industry’s 3% decline. Plus, it’s raised 2025 adjusted EBITDA guidance while curbing operating expenses. 📈 Discover what’s driving MD’s growth here 👉 https://www.zacks.com/stock/news/2751059/heres-why-pediatrix-medical-shares-are-attracting-investors-now?cid=sm-stocktwits-2-2751059-body-12317&ADID=SYND_STOCKTWITS_TWEET_2_2751059_BODY_12317
0 · Reply
ZacksResearch
ZacksResearch Sep. 12 at 5:28 PM
$MD is ripping higher — here’s why investors are piling in 👀 Strong earnings, rising revenues, aggressive cost cuts, and a fresh $250M buyback are fueling serious momentum. Full breakdown here 👉 https://www.zacks.com/stock/news/2751059/heres-why-pediatrix-medical-shares-are-attracting-investors-now?cid=sm-stocktwits-2-2751059-teaser-12314&ADID=SYND_STOCKTWITS_TWEET_2_2751059_TEASER_12314
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 6:16 PM
$MD Brilliant piece that captures MD's situation perfectly. So if you want to update your understanding of MD or get to know MD better, this is essential reading. https://beyondspx.com/quote/MD/analysis/pediatrix-s-focused-resurgence-clinical-excellence-fuels-growth-nyse-md
0 · Reply
JarvisFlow
JarvisFlow Sep. 5 at 11:00 AM
Leerink Partners has updated their rating for Pediatrix Medical Group ( $MD ) to Market Perform with a price target of 17.
0 · Reply
Latest News on MD
Pediatrix Medical Group Reports Second Quarter Results

Aug 5, 2025, 6:00 AM EDT - 2 months ago

Pediatrix Medical Group Reports Second Quarter Results


Pediatrix Board Appoints Kurt D. Newman, M.D.

Jul 1, 2025, 4:05 PM EDT - 3 months ago

Pediatrix Board Appoints Kurt D. Newman, M.D.


Pediatrix Medical Group Reports First Quarter Results

May 6, 2025, 6:00 AM EDT - 5 months ago

Pediatrix Medical Group Reports First Quarter Results


Top 3 Health Care Stocks You May Want To Dump In February

Feb 20, 2025, 3:50 PM EST - 8 months ago

Top 3 Health Care Stocks You May Want To Dump In February

LUNG SWTX


Pediatrix Medical Group Reports Fourth Quarter Results

Feb 20, 2025, 6:00 AM EST - 8 months ago

Pediatrix Medical Group Reports Fourth Quarter Results


Pediatrix Medical Group Reports Third Quarter Results

Nov 1, 2024, 6:00 AM EDT - 1 year ago

Pediatrix Medical Group Reports Third Quarter Results


Pediatrix Board Appoints Sylvia Young as Independent Director

May 4, 2023, 4:05 PM EDT - 2 years ago

Pediatrix Board Appoints Sylvia Young as Independent Director


James D. Swift, M.D., Elected to Pediatrix Board of Directors

Mar 8, 2023, 5:36 PM EST - 2 years ago

James D. Swift, M.D., Elected to Pediatrix Board of Directors


Pediatrix Announces Leadership Transitions

Dec 15, 2022, 4:41 PM EST - 3 years ago

Pediatrix Announces Leadership Transitions


Pediatrix: These 5 Graphs Suggest It's A Buy

Sep 29, 2022, 12:52 PM EDT - 3 years ago

Pediatrix: These 5 Graphs Suggest It's A Buy


Pediatrix Medical Group Comments on No Surprises Act Final Rule

Aug 22, 2022, 3:00 PM EDT - 3 years ago

Pediatrix Medical Group Comments on No Surprises Act Final Rule


Pediatrix: Seeking 46% Return Objective As Speculative Buy

Jul 14, 2022, 12:06 AM EDT - 3 years ago

Pediatrix: Seeking 46% Return Objective As Speculative Buy


SirBensonbot
SirBensonbot Oct. 2 at 11:21 AM
$MD long
0 · Reply
highnihilism
highnihilism Oct. 1 at 11:17 AM
$UTES Virtus Reaves Utilities ETF Trades: 1 | Total $: 820 | 0.00 × 90-Day Avg $: 820 | Call $: 820 | Put $: 0 | Single-Leg: 100% | Multi-Leg: – | Contingent: – $PUK Prudential Public Limited Company Trades: 3 | Total $: 820 | 0.12 × 90-Day Avg $: 6.6 K | Call $: 820 | Put $: 0 | Single-Leg: 100% | Multi-Leg: – | Contingent: – $KCE SPDR S&P Capital Markets ETF Trades: 2 | Total $: 819 | 1.11 × 90-Day Avg $: 740 | Call $: 819 | Put $: 0 | Single-Leg: – | Multi-Leg: – | Contingent: 100% $MD Pediatric Medical Group Trades: 7 | Total $: 1.5 K | 0.51 × 90-Day Avg $: 3 K | Call $: 819 | Put $: 702 | Single-Leg: 100% | Multi-Leg: – | Contingent: –
0 · Reply
highnihilism
highnihilism Sep. 29 at 6:28 PM
S&P MidCap 400 (Health Care) → $INCY Incyte $JAZZ Jazz Pharmaceuticals $LH Laboratory Corp. of America $MD Mednax $MOH Molina Healthcare
0 · Reply
highnihilism
highnihilism Sep. 24 at 7:12 PM
Russell 2000 (Healthcare) → $JAZZ Jazz Pharmaceuticals $LH Labcorp $LMAT LeMaitre Vascular $MD Mednax $MDGL Madrigal Pharmaceuticals
0 · Reply
highnihilism
highnihilism Sep. 24 at 12:33 PM
Russell 2000 (Healthcare) → $JAZZ Jazz Pharmaceuticals $LH Labcorp $LMAT LeMaitre Vascular $MD Mednax $MDGL Madrigal Pharmaceuticals
0 · Reply
highnihilism
highnihilism Sep. 17 at 10:13 AM
IWM: Russell 2000 → $MD Pediatrix Medical Group $ARKO Arko Corp. $OSW OnespaWorld $CTLP Cantaloupe $BHR Braemar Hotels & Resorts
0 · Reply
ZacksResearch
ZacksResearch Sep. 12 at 6:28 PM
$MD up 29.6% YTD — time to take notice? 🚀 With a low forward P/E of 9.46 and a Zacks Rank #1 (Strong Buy), Pediatrix Medical is outpacing the industry’s 3% decline. Plus, it’s raised 2025 adjusted EBITDA guidance while curbing operating expenses. 📈 Discover what’s driving MD’s growth here 👉 https://www.zacks.com/stock/news/2751059/heres-why-pediatrix-medical-shares-are-attracting-investors-now?cid=sm-stocktwits-2-2751059-body-12317&ADID=SYND_STOCKTWITS_TWEET_2_2751059_BODY_12317
0 · Reply
ZacksResearch
ZacksResearch Sep. 12 at 5:28 PM
$MD is ripping higher — here’s why investors are piling in 👀 Strong earnings, rising revenues, aggressive cost cuts, and a fresh $250M buyback are fueling serious momentum. Full breakdown here 👉 https://www.zacks.com/stock/news/2751059/heres-why-pediatrix-medical-shares-are-attracting-investors-now?cid=sm-stocktwits-2-2751059-teaser-12314&ADID=SYND_STOCKTWITS_TWEET_2_2751059_TEASER_12314
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 6:16 PM
$MD Brilliant piece that captures MD's situation perfectly. So if you want to update your understanding of MD or get to know MD better, this is essential reading. https://beyondspx.com/quote/MD/analysis/pediatrix-s-focused-resurgence-clinical-excellence-fuels-growth-nyse-md
0 · Reply
JarvisFlow
JarvisFlow Sep. 5 at 11:00 AM
Leerink Partners has updated their rating for Pediatrix Medical Group ( $MD ) to Market Perform with a price target of 17.
0 · Reply
wisdom_trade
wisdom_trade Aug. 29 at 6:46 PM
$IOT $NVDA $MD AVGO new generation AI stocks
0 · Reply
ZacksResearch
ZacksResearch Aug. 19 at 5:12 PM
$MD's shareholder-friendly moves: Is it time to buy? 📈 Pediatrix Medical has expanded its share repurchase authorization to $250M, leveraging strong cash flow and solidifying value for investors. With a 21.9% YTD gain, a low forward P/E of 9.54x, and a Zacks Rank #1, the setup looks promising. Discover why MD could be a strong addition to your portfolio 👉 https://www.zacks.com/stock/news/2735167/pediatrix-medical-refills-its-buyback-prescription-with-250m-dose?cid=sm-stocktwits-2-2735167-body-8425&ADID=SYND_STOCKTWITS_TWEET_2_2735167_BODY_8425
0 · Reply
ZacksResearch
ZacksResearch Aug. 19 at 4:12 PM
$MD just prescribed itself a $250M buyback 💊 Backed by stronger cash flow, leaner operations, and a robust 2025 profit outlook, management is doubling down on shareholder returns. See the full breakdown here 👉 https://www.zacks.com/stock/news/2735167/pediatrix-medical-refills-its-buyback-prescription-with-250m-dose?cid=sm-stocktwits-2-2735167-teaser-8424&ADID=SYND_STOCKTWITS_TWEET_2_2735167_TEASER_8424
0 · Reply
ZacksResearch
ZacksResearch Aug. 8 at 7:16 PM
$MD soars 12.1% post-Q2 earnings — what's driving the rally? 🚀 Pediatrix crushed EPS estimates by 26.2%. Quarterly results were aided by higher patient volumes, improved patient acuity, and slashed operating expenses. However, net revenues dipped 7% due to practice dispositions. 📉 Discover the full breakdown here 👉 https://www.zacks.com/stock/news/2685263/pediatrix-medicals-q2-earnings-beat-on-strong-patient-volumes?cid=sm-stocktwits-2-2685263-body-7023&ADID=SYND_STOCKTWITS_TWEET_2_2685263_BODY_7023
0 · Reply
Estimize
Estimize Aug. 4 at 6:00 PM
$MD reports before the open tomorrow, Estimize Consensus +0.02 EPS and +1.78M Revs compared to WS http://www.estimize.com/md/fq2-2025?utm_c
0 · Reply
LewisDaKat
LewisDaKat Jun. 15 at 9:55 PM
News (MD) Technical Data https://marketwirenews.com/news-releases/-md-technical-data-8912284207115659.html $MD
0 · Reply
PitchStack
PitchStack Jun. 6 at 9:31 PM
$MD Our team recently reviewed a new Pediatrix stock pitch from Substack. Pediatrix (NYSE: MD) 🇺🇸 | $ 1.20 B | Healthcare | Turnaround Pediatrix Medical Group, Inc. provides specialised newborn, maternal-fetal, and paediatric cardiology care services in the United States and Puerto Rico. By divesting non-core units, Pediatrix has improved its margins and financial stability. The company benefits from macroeconomic tailwinds, such as increased demand for neonatal and maternal-fetal care due to demographic trends. Additionally, its strong presence in high-growth regions like the Southeast supports sustained growth and margin recovery. Link: https://deepvaluecapitalbykyler.substack.com/p/the-nicu-specialist-built-to-last Our team also analysed 18 other pitches, with the full breakdown available at PitchStack: www.pitchstack-investing.com"
0 · Reply
ZacksResearch
ZacksResearch May. 28 at 1:58 PM
$MD defies industry trends with a strong YTD gain! 🚀 Pediatrix Medical is up 5.6% YTD, outpacing the industry’s 6.4% decline. Their forward P/E of 8.72 is notably below the industry average, signaling potential value. Discover why MD could be a solid addition to your portfolio 👉 https://www.zacks.com/commentary/2478230/heres-why-you-should-add-pediatrix-medical-to-your-portfolio-now?cid=sm-stocktwits-2-2478230-body&ADID=SYND_STOCKTWITS_TWEET_2_2478230_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 28 at 12:45 PM
$MD rises 5.6% YTD as earnings beat, hospital deals and lower costs drive growth. The Zacks Rank #2 signals strong near-term prospects. Explore further: https://www.zacks.com/stock/news/2478230/heres-why-you-should-add-pediatrix-medical-to-your-portfolio-now?cid=sm-stocktwits-2-2478230-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2478230_TEASER
0 · Reply
Rodsgo
Rodsgo May. 23 at 12:17 PM
0 · Reply
Winning_calls
Winning_calls May. 17 at 12:09 AM
$MD 👌🫡🫡
0 · Reply
vjtweet
vjtweet May. 16 at 1:48 AM
$MD playbook here ... if it acts well. No position yet.
0 · Reply